QGEN
Qiagen
October 20, 2026 · intraday
- Rarity
- 1.78
- Peak move
- +6.34%
- Float cap
- $9.5B
Qiagen is a Netherlands-based life sciences and molecular diagnostics company that sells sample-preparation technologies, assays, instruments and bioinformatics software for isolating and analyzing DNA, RNA and proteins from blood, tissue and other materials. It serves over 500,000 customers, including academic and pharmaceutical research laboratories, clinical healthcare providers, and applied-testing markets such as forensics and food safety. Its main franchises include QuantiFERON latent-tuberculosis testing, QIAstat-Dx syndromic panels and QIAcuity digital PCR.
Where do you see this going?
no votes yetVoting closed at 4:00 PM ET.
What we found
no events · 0 from SEC or newswire · 0 timed with the moveNothing found.We searched SEC filings, the newswires and the open web across the three days around this move and found no public information that explains it.